Subscribe To
ENDP / Endo (ENDP) Phase II Study for Frozen Shoulder Disappoints
ENDP News
By InvestorPlace
August 9, 2022
Endo International (ENDP) Stock Plunges Amid Bankruptcy Warning
It hasn't been a good run for Endo International (NASDAQ: ENDP ), and Tuesday isn't making it any better. Shares of ENDP stock are down more than 40% more_horizontal
By Zacks Investment Research
July 4, 2022
Endo (ENDP) Phase II Study for Frozen Shoulder Disappoints
Endo (ENDP) mid-stage study of collagenase clostridium histolyticum (or CCH) for treating frozen shoulder disappoints. more_horizontal
By Benzinga
July 1, 2022
Why Endo International Shares Are Getting Hammered Today
Endo International PLCĀ (NASDAQ: ENDP) shares are trading lower by 16.86% to $0.39 after the company provided top-line results from its Phase 2 study more_horizontal
By InvestorPlace
June 30, 2022
Endo International (ENDP) Stock Plunges 20% After Missing Interest Payment
Here's what investors may want to know about today's 20% downside move in ENDO stock, a day after this stock rocketed 90% higher. The post Endo Intern more_horizontal
By InvestorPlace
June 28, 2022
Why Is Endo International (ENDP) Stock Up 90% Today?
Endo International has been surging all day but it isn't just Plan B that has kept it rising. Here's why ENDP stock is a name to watch. more_horizontal
By The Motley Fool
May 18, 2022
Why Shares of Endo International Plummeted 69% on Wednesday
Reports that the specialty pharmaceutical company is looking to restructure debt prompted the drop. more_horizontal
By Benzinga
May 18, 2022
What Is Happening With Endo Shares Today
Endo International PlcĀ (NASDAQ: ENDP) initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than more_horizontal
By Zacks Investment Research
May 6, 2022
Endo (ENDP) Beats on Q1 Earnings, Guides Weak Q2 Results
Endo (ENDP) tops Q1 earnings and sales estimates. However, Vasostrict faces generic competition and the guidance for Q2 is dismal. more_horizontal